Table 6 Association between LV remodelling and circulating lncRNAs in patients with well-controlled type 2 diabetes.

From: Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes

 

β

P-value

 

β

P-value

Model 1

Model 1

MIAT

0.396

0.005*

SENCR

0.345

0.015*

Age

0.172

0.211

Age

0.168

0.233

BMI

0.305

0.029*

BMI

0.236

0.092

Model 2

Model 2

Association between LVMV-ratio and circulating MIAT for model 2 and each of following variables:

Association between LVMV-ratio and circulating SENCR for model 2 and each of following variables:

Plasma fasting glucose

0.411

0.005*

Plasma fasting glucose

0.353

0.015*

Plasma fasting insulin

0.425

0.003*

Plasma fasting insulin

0.333

0.021*

Time since diagnosis of diabetes

0.404

0.005*

Time since diagnosis of diabetes

0.357

0.014*

SBP

0.385

0.007*

SBP

0.334

0.019*

DBP

0.375

0.008*

DBP

0.323

0.023*

Heart rate

0.390

0.006*

Heart rate

0.340

0.017*

Myocardial steatosis

0.396

0.006*

Myocardial steatosis

0.349

0.015*

NT-proBNP

0.401

0.005*

NT-proBNP

0.365

0.011*

us-CRP

0.389

0.008*

us-CRP

0.348

0.018*

  1. *Statistically significant.